Clinical Trials for Melanocytic Tumor of the Eye
Melanocytic tumors of the eye arise from pigment-producing cells within the uveal tract or eyelid margins in dogs and cats. While some are benign, uveal melanomas and limbal melanomas can be locally invasive or metastasize to distant sites. Clinical trials at veterinary universities are researching improved diagnostic techniques and novel treatment approaches including targeted therapies for aggressive cases.
11 active trials currently enrolling
Trials available at institutions in:
Understanding Melanocytic Tumor of the Eye in Pets
Melanocytic tumors of the eye arise from pigment-producing cells in or around the eye and can range from benign to locally invasive or metastatic. Common locations include the uveal tract and eyelid margins.
Who it tends to affect
- Typical size: Affects both dogs and cats
- Typical age: Most commonly diagnosed in middle-aged to older animals
Can my pet join — does breed matter?
Trials typically enroll based on tumor location within the eye, how invasive it appears, and whether prior treatment was given. Both species and all breeds are generally eligible.
Most trials are open to all breeds and set requirements by size, weight, age, and diagnosis instead. Our matching service checks your pet's specific details against each study's actual requirements.
Where Melanocytic Tumor of the Eye Trials Are Running
Active research locations are spread across the country. Current coverage by region:
States with active sites include: MO, WI, CO, KS, MI. We expand the search to nearby states when there's no local match.
What Melanocytic Tumor of the Eye Trials Typically Cost
Many trials cover part or all of treatment costs. Of the 11 trials we're currently tracking for melanocytic tumor of the eye:
The trials themselves are run by research institutions — we don't charge for them. Funding status changes as studies open and close, so we confirm current coverage when we match your pet.
What Melanocytic Tumor of the Eye Research Is Focused On
Current studies for melanocytic tumor of the eye are exploring approaches like:
- •Targeted therapy for ocular tumors
- •Immunotherapy approaches
- •Laser and local ablative treatment
- •Systemic therapy for metastatic disease
How it works
Tell us about your pet
Share the diagnosis, your pet's age and size, and your location. It takes a few minutes — no account needed.
We research current trials
We check open studies against your pet's actual eligibility — diagnosis, stage, location, and prior treatment. Most matches come back in 2–3 days.
You get your matches
A personalized list of trials your pet may qualify for, with locations, funding status, and exactly how to enroll.
The trials themselves are free and run by research institutions. Our fee covers the research and eligibility matching — and if we don't find any matches for your pet, you don't pay.
Find trials for my pet with Melanocytic Tumor of the Eye now
Our matching service screens all 11 active Melanocytic Tumor of the Eye trials against your pet’s specific profile — age, breed, stage, and location.
$7 to see your matches · $23 only if trials are found
Check My Pet’s Eligibility Now →Find Trials for Your Pet
Our free matching service screens 147 active trials at 25 accredited veterinary universities. Submit once, get matched to every relevant trial.
Find Trials for Your Pet